1d
Zacks Investment Research on MSNHere's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Benchmark raised the firm’s price target on Aqua Metals (AQMS) to $3 from $1 and keeps a Speculative Buy rating on the shares. The company ...
Discover why Freeport-McMoRan Inc. lags despite copper's rally in 2025. Click to learn about FCX risks from tariffs, weak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results